Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3010% above fair value
$3.76−0.01 (-0.27%)
Close on Nov 17, 2026Market cap $91.09MP/E –Yield –
Exagen profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Exagen's profit margin for the twelve months ending Jun 30, 2026 was -26.6%. For fiscal 2025 it was -30.0%, against -27.2% the year before. The highest annual figure on record is -24.7% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -30.0% | −2.8 |
| FY2024 | Dec 31, 2024 | -27.2% | +17.9 |
| FY2023 | Dec 31, 2023 | -45.1% | +58.9 |
| FY2022 | Dec 31, 2022 | -104.0% | −48.4 |
| FY2021 | Dec 31, 2021 | -55.6% | −15.8 |
| FY2020 | Dec 31, 2020 | -39.8% | −9.9 |
| FY2019 | Dec 31, 2019 | -29.8% | −5.1 |
| FY2018 | Dec 31, 2018 | -24.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -16.0% | +9.8 |
| Q1 FY2026 | Mar 31, 2026 | -22.9% | +1.3 |
| Q4 FY2025 | Dec 31, 2025 | -28.1% | −0.6 |
| Q3 FY2025 | Sep 30, 2025 | -41.1% | −0.9 |
| Q2 FY2025 | Jun 30, 2025 | -25.8% | −6.1 |
| Q1 FY2025 | Mar 31, 2025 | -24.2% | −0.9 |
| Q4 FY2024 | Dec 31, 2024 | -27.5% | +12.9 |
| Q3 FY2024 | Sep 30, 2024 | -40.2% | +0.2 |
| Q2 FY2024 | Jun 30, 2024 | -19.7% | +15.8 |
| Q1 FY2024 | Mar 31, 2024 | -23.3% | +45.2 |
| Q4 FY2023 | Dec 31, 2023 | -40.5% | +71.3 |
| Q3 FY2023 | Sep 30, 2023 | -40.4% | +14.6 |
| Q2 FY2023 | Jun 30, 2023 | -35.5% | +157.3 |
| Q1 FY2023 | Mar 31, 2023 | -68.5% | +30.4 |
| Q4 FY2022 | Dec 31, 2022 | -111.8% | −56.2 |
| Q3 FY2022 | Sep 30, 2022 | -55.0% | +3.6 |
| Q2 FY2022 | Jun 30, 2022 | -192.8% | −142.6 |
| Q1 FY2022 | Mar 31, 2022 | -98.8% | −40.2 |
| Q4 FY2021 | Dec 31, 2021 | -55.6% | −28.3 |
| Q3 FY2021 | Sep 30, 2021 | -58.6% | −18.6 |
| Q2 FY2021 | Jun 30, 2021 | -50.2% | −12.6 |
| Q1 FY2021 | Mar 31, 2021 | -58.6% | −0.6 |
| Q4 FY2020 | Dec 31, 2020 | -27.3% | +6.1 |
| Q3 FY2020 | Sep 30, 2020 | -40.0% | −9.9 |
| Q2 FY2020 | Jun 30, 2020 | -37.6% | −11.0 |
| Q1 FY2020 | Mar 31, 2020 | -58.0% | −28.8 |
| Q4 FY2019 | Dec 31, 2019 | -33.4% | −19.7 |
| Q3 FY2019 | Sep 30, 2019 | -30.1% | −8.7 |
| Q2 FY2019 | Jun 30, 2019 | -26.6% | – |
| Q1 FY2019 | Mar 31, 2019 | -29.2% | – |
| Q4 FY2018 | Dec 31, 2018 | -13.7% | – |
| Q3 FY2018 | Sep 30, 2018 | -21.4% | – |
See a number that looks wrong?